MedPath

Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance

Not Applicable
Completed
Conditions
Methicillin-resistant Staphylococcus Aureus
Interventions
Drug: MRSA Decolonization
Behavioral: Standard-of-Care Education
Registration Number
NCT01209234
Lead Sponsor
University of California, Irvine
Brief Summary

This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventing MRSA infections in the large group of high risk MRSA-positive patients being discharged from hospitals. Findings could potentially impact best practice for the 1.8 million MRSA carriers who are discharged from US hospitals each year.

Detailed Description

This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventing MRSA infections in the large group of high risk MRSA+ patients being discharged from hospitals. Findings could potentially impact best practice for the 1.8 million MRSA carriers who are discharged from US hospitals each year.

Specific Aims:

Methicillin-resistant Staphylococcus aureus (MRSA) is arguably the most important single pathogen in healthcare-associated infection when accounting for virulence, prevalence, diversity of disease spectrum, and propensity for widespread transmission. MRSA infection causes or complicates 300,000 hospitalizations each year \[Klein, Smith, Laxminarayan\], a number which has doubled in the past five years. An additional 1.5 million hospitalized patients either acquire or already harbor the pathogen without current infection. Altogether, these 1.8 million MRSA inpatient carriers experience a high amount of MRSA invasive disease in the year following discharge. Due to increased delivery of complex medical care at home or other post-hospital settings, more and more patients experience serious healthcare-associated morbidity after hospital discharge.\[Huang, Platt; Huang, Hinrichsen, Stulgis et al.\] In fact, over 80% of patients admitted for MRSA infection have had prior healthcare exposures and are at high risk for repeated MRSA infection.\[Huang, Platt; Huang, Hinrichsen, Stulgis et al.; Klevens, Morrison, Nadle, et al.\]

Project CLEAR compares two strategies to reduce infection and re-hospitalization due to MRSA among patients being discharged from hospitals. Our trial will compare a long-term regimen aimed at eradicating MRSA body reservoirs with patient education on general hygiene and self care, which is the current standard of care. Our specific aims are:

* To conduct a randomized controlled trial of serial decolonization versus standard-of-care patient education among MRSA carriers upon hospital discharge to reduce post-discharge MRSA infection and re-hospitalization for one year

* To identify predictors of a) infection or re-hospitalization due to MRSA, and b) successful MRSA decolonization, including patient demographics, comorbidities, medical devices, risk behaviors, socioeconomic status, and colonizing MRSA genotype

* To estimate medical and non-medical costs of MRSA infection among MRSA carriers and evaluate the potential for cost savings associated with decolonization

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2140
Inclusion Criteria
    1. At least 18 years old
    1. Have had a positive culture (a type of test) for MRSA during recent hospital admission or within the 30 days prior to admission or following discharge
    1. Able to give consent or have a primary caregiver provide consent
    1. Able to bathe or shower or have this consistently performed by a willing caregiver
Exclusion Criteria
    1. Known allergies to chlorhexidine or mupirocin

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MRSA DecolonizationMRSA DecolonizationParticipants in this arm will be instructed to complete a decolonization regimen that will involve a 5-day application of nasal mupirocin, oral CHG rinse, and CHG body wash twice a month.
Education ArmStandard-of-Care EducationPatients randomized to standard education will receive a binder with MRSA educational materials which will include or be based upon CDC guidance for MRSA patients at home. In addition, educational material on hygiene practices to prevent MRSA infection will be provided.
Primary Outcome Measures
NameTimeMethod
Time to MRSA Infection1 year

Time in days to MRSA inpatient or outpatient infection (analyzed with the use of unadjusted Cox proportional-hazard models to identify time to infection; the results we are reporting are number of participants who had an infection event at one year post discharge)

Secondary Outcome Measures
NameTimeMethod
Time to All-cause Infection (Steering Committee Modified Oct 2011)1 year

Time in days to all-cause infection (analyzed with the use of unadjusted Cox proportional-hazard models to identify time to infection; the results we are reporting are number of participants who had an infection event at one year)

Trial Locations

Locations (24)

Pacific Haven HealthCare Center

🇺🇸

Garden Grove, California, United States

West Anaheim Extended Care

🇺🇸

Anaheim, California, United States

Orange Coast Memorial Medical Center

🇺🇸

Fountain Valley, California, United States

St. Jude Medical Center

🇺🇸

Fullerton, California, United States

Regents Point at Windcrest

🇺🇸

Irvine, California, United States

Hoag Memorial Hospital Presbyterian

🇺🇸

Newport Beach, California, United States

Country Villa Plaza

🇺🇸

Santa Ana, California, United States

Harbor-UCLA Medical Center

🇺🇸

Torrance, California, United States

Providence Little Company of Mary Medical Center

🇺🇸

Torrance, California, United States

Covington Care Center

🇺🇸

Aliso Viejo, California, United States

Downey Regional Medical Center

🇺🇸

Downey, California, United States

Chapman Care Center

🇺🇸

Garden Grove, California, United States

St. Mary Medical Center

🇺🇸

Long Beach, California, United States

Saddleback Memorial Medical Center - Laguna Hills

🇺🇸

Laguna Hills, California, United States

Mission Hospital

🇺🇸

Mission Viejo, California, United States

Long Beach Memorial Medical Center

🇺🇸

Long Beach, California, United States

Villa Elena Health Care Center

🇺🇸

Norwalk, California, United States

UC Irvine Medical Center

🇺🇸

Orange, California, United States

Royale Healthcare

🇺🇸

Santa Ana, California, United States

Little Company of Mary - San Pedro

🇺🇸

San Pedro, California, United States

Torrance Memorial Medical Center

🇺🇸

Torrance, California, United States

Ventura County Medical Center

🇺🇸

Ventura, California, United States

Fountain Valley Regional Hospital & Medical Center

🇺🇸

Fountain Valley, California, United States

Saddleback Memorial Medical Center - San Clemente

🇺🇸

San Clemente, California, United States

© Copyright 2025. All Rights Reserved by MedPath